Diseases, Conditions, Syndromes

Roche teams up with Atea in US on oral coronavirus treatment

Swiss pharmaceuticals giant Roche said Thursday it is collaborating with Atea Pharmaceuticals on the development of an orally administered drug to treat coronavirus patients who have not been hospitalised.

Diseases, Conditions, Syndromes

Peru surpasses 200,000 coronavirus infections: health ministry

Peru emerged as a global COVID-19 hotspot on Tuesday as the health ministry registered more than 200,000 cases, ranking the South American country as the eighth-highest in the world by number of infections.

Other

Novartis profit up as world flocks to buy medecine

Swiss pharma giant Novartis on Tuesday reported higher profits for the first quarter as customers rushing to buy treatments during the coronavirus outbreak boosted the bottom line.

Medications

Lundbeck profit jumps but warns on generic pressure

Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.

Medications

Bayer profits up 11.5 percent on new drugs

German chemical and pharmaceutical company Bayer AG said Thursday that its net profit rose 11.5 percent in the first quarter as new drugs, led by blood thinner Xarelto, boosted sales.

page 3 from 4